The board of directors of the Swedish clinical group CAPIO (annual turnover €1.35 bn with 14,500 employees) has accepted the improved buy out offer from the investment funds APAX PARTNERS and NORDIC CAPITAL, which increased their price from SKr153 to SKr167 per share, which makes the company worth SKr17 bn.